TTM
34.9%
YoY change
+24.61pp
Trough year (2008)
-3731.0%
Peak year (2025)
34.2%
Latest annual
34.2%
EBITDA Margin history chart for Incyte (INCY) from 1995 to 2025
Latest: 34.2%
EBITDA Margin change chart for Incyte (INCY) from 1995 to 2025
Latest: +24.61pp
EBITDA Margin history table for Incyte (INCY) from 1995 to 2025
| 2025 | 34.2% | +24.61pp | ||
| 2024 | 9.6% | -15.26pp | ||
| 2023 | 24.9% | +7.21pp | ||
| 2022 | 17.7% | -3.44pp | ||
| 2021 | 21.1% | +27.79pp | ||
| 2020 | -6.7% | -31.85pp | ||
| 2019 | 25.2% | +16.03pp | ||
| 2018 | 9.1% | +25.62pp | ||
| 2017 | -16.5% | -34.98pp | ||
| 2016 | 18.5% | +5.49pp | ||
| 2015 | 13.0% | +5.25pp | ||
| 2014 | 7.8% | +11.98pp | ||
| 2013 | -4.2% | -14.96pp | ||
| 2012 | 10.7% | +133.26pp | ||
| 2011 | -122.5% | -143.69pp | ||
| 2010 | 21.2% | +1349.59pp | ||
| 2009 | -1328.4% | +2402.58pp | ||
| 2008 | -3731.0% | -3521.02pp | ||
| 2007 | -210.0% | +41.27pp | ||
| 2006 | -251.2% | +928.87pp | ||
| 2005 | -1180.1% | -226.21pp | ||
| 2004 | -953.9% | -714.80pp | ||
| 2003 | -239.1% | -123.35pp | ||
| 2002 | -115.8% | -107.99pp | ||
| 2001 | -7.8% | +6.52pp | ||
| 2000 | -14.3% | -12.83pp | ||
| 1999 | -1.5% | -23.72pp | ||
| 1998 | 22.3% | +6.48pp | ||
| 1997 | 15.8% | +21.51pp | ||
| 1996 | -5.7% | +60.67pp | ||
| 1995 | -66.4% | — |
- 202534.2%+24.61pp
- 20249.6%-15.26pp
- 202324.9%+7.21pp
- 202217.7%-3.44pp
- 202121.1%+27.79pp
- 2020-6.7%-31.85pp
- 201925.2%+16.03pp
- 20189.1%+25.62pp
- 2017-16.5%-34.98pp
- 201618.5%+5.49pp
- 201513.0%+5.25pp
- 20147.8%+11.98pp
- 2013-4.2%-14.96pp
- 201210.7%+133.26pp
- 2011-122.5%-143.69pp
- 201021.2%+1349.59pp
- 2009-1328.4%+2402.58pp
- 2008-3731.0%-3521.02pp
- 2007-210.0%+41.27pp
- 2006-251.2%+928.87pp
- 2005-1180.1%-226.21pp
- 2004-953.9%-714.80pp
- 2003-239.1%-123.35pp
- 2002-115.8%-107.99pp
- 2001-7.8%+6.52pp
- 2000-14.3%-12.83pp
- 1999-1.5%-23.72pp
- 199822.3%+6.48pp
- 199715.8%+21.51pp
- 1996-5.7%+60.67pp
- 1995-66.4%—
EBITDA Margin values are taken from Incyte's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Incyte (INCY)
According to Incyte's latest reported financial statements, the company's latest reported EBITDA margin is 34.9%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Incyte (INCY) most recent annual EBITDA margin stands at 34.24% (2025) – expanded 24.6 percentage points year-over-year.
The record annual EBITDA margin stands at 34.24%, reached in 2025; the historical low of -3731.00% was recorded in 2008.
Incyte EBITDA Margin by Year
Incyte EBITDA Margin 2025: 34.2%
2025's EBITDA margin for Incyte came in at 34.24%, expanded 24.6 percentage points from 2024. This figure represents the highest annual value in the available history.
Incyte EBITDA Margin 2024: 9.6%
Incyte posted EBITDA margin of 9.62% in 2024, contracted 15.3 percentage points from 2023.
Incyte EBITDA Margin 2023: 24.9%
In 2023, Incyte reported EBITDA margin of 24.88%, expanded 7.2 percentage points from 2022.
Incyte EBITDA Margin 2022: 17.7%
Incyte EBITDA margin in 2022 was 17.66%, contracted 3.4 percentage points from 2021.
Incyte EBITDA Margin 2021: 21.1%
Incyte EBITDA margin in 2021 was 21.10%.
See more financial history for Incyte (INCY).
Sector peers by EBITDA Margin
Healthcare peers of Incyte (INCY), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 45.9% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 5.1% |
- 55.4%
- 46.6%
- 45.9%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation